Abstract:Background: Monocytes contribute to the initiation and propagation of venous thrombosis. Little is known about the roles monocytes play in arterial thrombosis, the cause of stroke and MI. Methods: We investigated how chemokine receptor 2 (CCR2) knockout ( ) affects platelet function, blood coagulation, thrombus volume, and thrombolytic susceptibility in 627 mice with FeCl3–mediated carotid arterial thrombosis: three CX3CR1–GFP mice, 326 C57BL/6 mice, and 288 CCR2 mice. We performed i) intravital microscopy imaging of leukocyte recruitment to carotid thrombus, ii) flow cytometry&ndashbased quantification of leukocytes in blood vs. thrombus and leukocyte-platelet aggregates in blood, iii) platelet aggregometry, iv) coagulation assays, v) micro&ndashcomputed tomography (microCT)&ndashbased thrombus imaging using gold nanoparticles after tissue plasminogen activator (tPA) therapy with or without either a) CCR2 siRNA pretreatment (for 3 days) or post&ndashtreatment or b) clopidogrel pretreatment (for 7 days), and vi) histology including scanning electron microscopy. Results: Intravital microscopy and flow cytometry showed that both neutrophils and monocytes were recruited to the acute arterial thrombus, as observed 30 minutes post&ndashthrombosis. Platelet function tests demonstrated platelet aggregation to be lower in the whole blood of CCR2 mice (vs. C57BL/6 mice) but not in their leukocyte&ndashfree platelet rich plasma, suggesting this platelet dysfunction is cell&ndashmediated. Flow cytometry experiments revealed lower numbers of monocyte&ndashplatelet aggregates (MPAs), a marker of platelet activity, in the blood of CCR2 mice, compared to C57BL/6 mice. Blood levels of FXIII and monocyte levels of FXIII&ndashA were increased after carotid thrombosis in C57BL/6 mice but not CCR2 mice. Further, in vivo microCT and histology, respectively, showed that CCR2 mice had smaller and more porous thrombi with less fibrin cross&ndashlinking, compared with C57BL/6 mice. MicroCT also demonstrated that tPA&ndashmediated thrombolysis was faster in CCR2 mice and CCR2 siRNA&ndashtreated mice, compared to C57BL/6 mice. In addition, clopidogrel had a greater effect on inducing thrombus formation with smaller sizes after FeCl application, while CCR2 had a greater effect on dissolving thrombus faster after tPA administration. Conclusions: CCR2 antagonism decreases platelet aggregation and reduces FXIII levels in blood and monocytes, thus driving arterial thrombosis towards the generation of a relatively small, porous, more lysable clot.

Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets

Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling

Distinct platelet interactions with soluble and immobilized von Willebrand factor modulate platelet adhesion and aggregation with differential impact on hemostasis and thrombosis

Targeting Thymidine Phosphorylase With Tipiracil Hydrochloride Attenuates Thrombosis Without Increasing Risk of Bleeding in Mice

Differential Impact In Vivo of Pf4-ΔCre–Mediated and Gp1ba-ΔCre–Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice

Ultra-high throughput-based screening for the discovery of antiplatelet drugs affecting receptor dependent calcium signaling dynamics

Structural insights into human ABCC4-mediated transport of platelet agonist and antagonist

Modulation Of Platelet Activation And Thrombus Formation Using A Pan-Pi3k Inhibitor S14161

Platelet Shp2 Negatively Regulates Thrombus Stability under High Shear Stress

Platelet integrin αIIbβ3 plays a key role in venous thrombogenesis in a mouse model

Inhibiting monocyte migration reduces arterial thrombosis and facilitates thrombolysis

Pharmacological inhibition of Septins with Forchlorfenuron attenuates thrombus formation in experimental thrombotic mice models with modulating multiple signaling pathways in platelets

The NMDA receptor regulates integrin activation, ATP release and arterial thrombosis through store-operated Ca2+ entry in platelets

Structural basis of prostaglandin efflux by MRP4

Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy

Targeting the RT loop of Src SH3 in Platelets Prevents Thrombosis without Compromising Hemostasis

Abstract 450: Phosphorylation of Platelet Αiibβ3 is Crucial for Arterial Thrombosis in Vivo and Microparticle Generation

Influence of Thrombolysis on the Safety and Efficacy of Blocking Platelet Adhesion or Secretory Activity in Acute Ischemic Stroke in Mice

Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.

Platelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model

[Platelet-specific Rictor knockout inhibits platelet production and activation and reduces thrombosis in mice]